We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Diagnostics

Image: Q-POC platform - Rapid PCR testing at the point of need (Photo courtesy of QuantuMDx)

Portable, Sample to Answer PCR Device Delivers Accurate Results in 30 Minutes at Point of Need

A portable and simple to use rapid multiplex PCR testing system delivers fast, accurate and actionable results in approximately 30 minutes at the point of need. More...
07 Sep 2022
Image: The DPP HIV-Syphilis System is PMA approved (Photo courtesy of Chembio)

Rapid POC Diagnostic Test for Syphilis Could Produce Results in Under 20 Minutes

The development of a rapid point-of-care test should allow for rapid diagnosis of an active syphilis infection and timely patient treatment, thus reducing the overall burden of syphilis in the U.S. More...
07 Sep 2022
Image: Histopathology of mucinous fibroplasia in prostate cancer (Photo courtesy of Cleveland Clinic)

African-Specific Molecular Taxonomy of Prostate Cancer Revealed

Prostate cancer is characterized by considerable geo-ethnic disparity. African ancestry is a significant risk factor for the disease, with 2.7-fold higher mortality rates across sub-Saharan Africa than global averages, yet the genetic and non-genetic factors underlying this is not known. More...
06 Sep 2022
Image: A simple blood test - administered before CAR-T cell treatment is initiated - may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy. Severe side effects can include seizures, brain swelling, and strokes. Evidence of a stroke (red arrows) is seen on this MRI scan of the brain of a patient who developed neurotoxic side effects after CAR-T cell therapy (Photo courtesy of Dr. Omar Butt, Washington University School of Medicine)

Elevated Blood Levels of Neurofilament Light Chain Predict Likelihood of Neurotoxicity Following CAR-T Immunotherapy

An elevated level of neurofilament light chain (NfL) in the blood plasma can identify which patients are likely to develop neurotoxic side effects in the days and weeks following CAR-T cell therapy. More...
06 Sep 2022
Image: SkylineDx has announced the commercial launch of Merlin Assay as CE-IVD kit in Europe (Photo courtesy of Pexels)

qPCR Assay Identifies Melanoma Patients With Low-Risk Tumor That Could Avoid Invasive Biopsy

A new test can identify melanoma patients with low-risk tumor to help avoid sentinel lymph node biopsy, an invasive surgical procedure used to determine metastatic spread of the cancer for staging purposes. More...
06 Sep 2022
Image: Artist’s conception of amyotrophic lateral sclerosis (ALS) (Photo courtesy of www.123rf.com)

Improved ALS Blood Test Requires Less Stringent Storage and Work Conditions

Improvements to the method for isolating extracellular vesicles from the blood of amyotrophic lateral sclerosis (ALS) patients have yielded a more robust test for detection of the disorder that may be used under routine laboratory conditions. More...
05 Sep 2022
Image: Artificial intelligence could help narrow heart attack gender gap (Photo courtesy of Unsplash)

AI Algorithm Combined With Blood Test Quickly and Accurately Diagnoses Heart Attacks in Women

An algorithm developed using artificial intelligence (AI) could help doctors to diagnose heart attacks in women more accurately and quicker than ever before. More...
05 Sep 2022
Gold Member
Automated MALDI-TOF MS System
EXS 3000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Homocysteine Quality Control
Liquichek Homocysteine Control
Gold Member
Automated Blood Culture System
EXB 120


Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
GLOBE SCIENTIFIC, LLC